Join the 'Thrombocytopenia' group to help and get support from people like you.

Thrombocytopenia Blog

FDA Approves New Indication for Promacta (eltrombopag)

Posted 20 Nov 2012 by Drugs.com

LONDON, Nov. 19, 2012 – GlaxoSmithKline plc announced today that the U.S. Food and Drug Administration (FDA) has approved Promacta for the treatment of thrombocytopenia (low blood platelet counts) in patients with chronic hepatitis C to allow them to initiate and maintain interferon-based therapy.  Promacta is the first supportive care treatment available to patients who are ineligible or poor candidates for interferon-based therapy due to their low blood platelet counts.  Promacta in combination with interferon-based therapy has been shown to improve a patient's chance of achieving a sustained virologic response (SVR) or viral cure. There are limitations to the use of Promacta in patients suffering from chronic hepatitis C-associated thrombocytopenia.  These include: Promacta should not be used in an attempt to normalize platelet counts; Promacta should be used only in patients with ch ... Read more

Related support groups: Hepatitis C, Thrombocytopenia, Promacta, Eltrombopag, Hepatitis C, Chronic

Ask a Question

Further Information

Related Condition Support Groups

Idiopathic (Immune) Thrombocytopenic Purpura, Thrombocytopenia Drug Induced, Thrombocytopenia Idiopathic, Thrombocytopenia Autoimmune, Bleeding Disorder

Related Drug Support Groups

prednisone, dexamethasone, Decadron, Deltasone, Promacta, Sterapred, Sterapred DS, eltrombopag, Liquid Pred, view more... Adrenocot, Cerezyme, Meticorten, Decaject, Dexpak Taperpak, Dalalone, Orasone, Prednicot, Dexamethasone Intensol, Baycadron, Prednicen-M, Medidex LA, Dexone, Dexacen-4, Solurex, Solurex LA, Decadron-LA, imiglucerase, Hexadrol, De-Sone LA, Dexacort-LA, Primethasone, Dexacorten, Dexone LA, Dexasone LA, Dexasone, Medidex